LivaNova

LIVNNasdaq United Kingdom Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$4.199 B

$76.22 +0.58%

Close of 7 Aug 2026

Revenue

$1.39B

#1345 by revenue

Earnings

-$242.5M

Loss-making

Shares outstanding

55,093,507

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#1MedtronicMDT$111.6B
#2IntegerITGR$4.26B
#3LivaNovaLIVN$4.20B
#4TransMedics GroupTMDX$2.91B
#5AxogenAXGN$2.50B

Where these numbers come from

Share counts and financials for LivaNova are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.